Suppr超能文献

预测糖尿病性黄斑水肿玻璃体切除术预后的因素:一项前瞻性研究的结果

Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.

作者信息

Shah S P, Patel M, Thomas D, Aldington S, Laidlaw D A H

机构信息

London School of Hygiene and Tropical Medicine, UK.

出版信息

Br J Ophthalmol. 2006 Jan;90(1):33-6. doi: 10.1136/bjo.2005.072934.

Abstract

AIM

To determine preoperative demographic, clinical, and optical coherence tomography (OCT) factors which might predict the visual and anatomical outcome at 1 year in patients undergoing vitrectomy and inner limiting membrane peel for diabetic macular oedema (DMO).

METHODS

A prospective, interventional case series of 33 patients who completed 1 year follow up. Measurements were taken preoperatively and at 1 year. Outcome measures were logMAR visual acuity (VA) and OCT macular thickness. A priori explanatory variables included baseline presence of clinical and/or OCT signs suggesting macular traction, grade of diabetic maculopathy, posterior vitreous detachment, fluorescein leakage and ischaemia on angiography, presence of subretinal fluid, and peroperative indocyanine green (ICG) use.

RESULTS

33 patients completed 1 year follow up. On average VA deteriorated by 0.035 logMAR (p = 0.40). Macular thickness significantly improved by a mean of 139 microm (95% CI; 211 to 67, p<0.001). Patients with evidence of clinical and/or OCT macular traction significantly improved logMAR acuity (logMAR improvement = 0.08) compared with patients without traction (logMAR deterioration 0.11, p = 0.01). Presence of subretinal fluid significantly predicted worse postoperative result (p = 0.01)

CONCLUSION

On average, patients showed a statistically significant improvement in central macular thickness following treatment but a marginal acuity worsening. Presence of subretinal fluid on OCT is hypothesised to be exudative rather than tractional in nature. The visual benefit of vitrectomy for DMO in this study was limited to patients who exhibit signs of macular traction either clinically and/or on OCT.

摘要

目的

确定在接受玻璃体切除术和内界膜剥除术治疗糖尿病性黄斑水肿(DMO)的患者中,哪些术前人口统计学、临床和光学相干断层扫描(OCT)因素可能预测1年后的视力和解剖学结果。

方法

一项前瞻性、干预性病例系列研究,纳入33例完成1年随访的患者。在术前和1年时进行测量。结果指标为logMAR视力(VA)和OCT黄斑厚度。先验解释变量包括提示黄斑牵拉的临床和/或OCT体征的基线存在情况、糖尿病性黄斑病变分级、玻璃体后脱离、血管造影上的荧光素渗漏和缺血、视网膜下液的存在以及术中吲哚菁绿(ICG)的使用情况。

结果

33例患者完成了1年随访。平均VA恶化了0.035 logMAR(p = 0.40)。黄斑厚度平均显著改善了139微米(95%可信区间;211至67,p<0.001)。有临床和/或OCT黄斑牵拉证据的患者与无牵拉的患者相比,logMAR视力显著改善(logMAR改善 = 0.08)(logMAR恶化0.11,p = 0.01)。视网膜下液的存在显著预测术后结果较差(p = 0.01)。

结论

平均而言,患者在治疗后中央黄斑厚度有统计学上的显著改善,但视力略有恶化。OCT上视网膜下液的存在被推测本质上是渗出性而非牵拉性的。在本研究中,玻璃体切除术对DMO的视力益处仅限于临床上和/或OCT上表现出黄斑牵拉迹象的患者。

相似文献

1
2
A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema.
Br J Ophthalmol. 2005 Jan;89(1):81-6. doi: 10.1136/bjo.2004.044966.
4
Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
Retina. 2008 Mar;28(3):410-9. doi: 10.1097/IAE.0b013e31816102f2.
8
Pars plana vitrectomy for diabetic macular oedema: OCT and functional correlations.
Eye (Lond). 2006 Jun;20(6):674-80. doi: 10.1038/sj.eye.6701945. Epub 2005 Oct 21.

引用本文的文献

2
Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy.
Graefes Arch Clin Exp Ophthalmol. 2022 Jul;260(7):2191-2200. doi: 10.1007/s00417-022-05595-9. Epub 2022 Feb 22.
3
Quantitative effect of subretinal fluid and intraretinal edema on visual acuity in uveitic cystoid macular edema.
J Ophthalmic Inflamm Infect. 2021 Oct 11;11(1):38. doi: 10.1186/s12348-021-00266-y.
4
The Evolving Treatment of Diabetic Retinopathy.
Clin Ophthalmol. 2020 Mar 4;14:653-678. doi: 10.2147/OPTH.S236637. eCollection 2020.
5
Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy.
Curr Diab Rep. 2019 Sep 16;19(10):106. doi: 10.1007/s11892-019-1210-x.
7
Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy.
Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1411-1418. doi: 10.1007/s00417-018-4009-6. Epub 2018 May 19.
8
Effects of kallidinogenase in patients undergoing vitrectomy for diabetic macular edema.
Int Ophthalmol. 2019 Jun;39(6):1307-1313. doi: 10.1007/s10792-018-0945-8. Epub 2018 May 12.
9
Ocriplasmin treatment for vitreomacular traction in real life: can the indication spectrum be expanded?
Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1907-1916. doi: 10.1007/s00417-017-3731-9. Epub 2017 Jul 5.
10
Vitrectomy for center-involved diabetic macular edema.
Clin Ophthalmol. 2016 Apr 26;10:735-42. doi: 10.2147/OPTH.S104906. eCollection 2016.

本文引用的文献

3
A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema.
Br J Ophthalmol. 2005 Jan;89(1):81-6. doi: 10.1136/bjo.2004.044966.
5
Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.
Graefes Arch Clin Exp Ophthalmol. 2005 Jan;243(1):20-5. doi: 10.1007/s00417-004-0958-z. Epub 2004 Jul 31.
6
Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema.
Graefes Arch Clin Exp Ophthalmol. 2004 Oct;242(10):845-52. doi: 10.1007/s00417-004-0939-2. Epub 2004 Jun 22.
7
Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular oedema.
Graefes Arch Clin Exp Ophthalmol. 2004 Aug;242(8):630-7. doi: 10.1007/s00417-003-0849-8. Epub 2004 Jun 22.
8
Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal.
Eur J Ophthalmol. 2004 Mar-Apr;14(2):137-43. doi: 10.1177/112067210401400209.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验